Effect of empagliflozin versus placebo on body composition in patients with acute myocardial infarction and type 2 diabetes mellitus: subgroup analysis of the EMBODY trial
Event:
ESC Congress 2020
Topic:
Pharmacotherapy
Session:
Risk Factors and Prevention ePosters
